Fresenius Kabi To Strengthen And Diversify Product Portfolio By Acquiring Akorn And Merck KGaA's Biosimilars Business
April 24 2017 - 4:25PM
Dow Jones News
Dow Jones received a payment from EQS/DGAP to publish this press
release.
@DJMTF
(END) Dow Jones Newswires
April 24, 2017 17:10 ET (21:10 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Fresenius SE and Company... (PK) (USOTC:FSNUY)
Historical Stock Chart
From Apr 2024 to May 2024
Fresenius SE and Company... (PK) (USOTC:FSNUY)
Historical Stock Chart
From May 2023 to May 2024